Efficacy and safety of single use duodenoscopes in comparison to reusable duodenoscopes for endoscopic retrograde cholangiopancreatography: A single center experience

Table 1 Baseline patients’ characteristics and endoscopic retrograde cholangiopancreatography details, n (%)

Characteristics	Total cohort (n = 133)	Single-use duodenoscope (n = 53)	Reusable duodenoscope (n = 80)	P value
Age (years), mean ± SD	69.54 ± 13.3	69.8 ± 12.4	68.9 ± 14.4	0.72
Gender (male, %)	53.3	56.6	51.3	0.59
Body mass index (kg/m2), mean ± SD	28.2 ± 7.9	30.5 ± 9.9	27.2 ± 6.3	0.07
Diabetes mellitus	32 (24)	16 (30.1)	16 (20)	0.2
Use of anti-coagulants	21 (15.7)	10 (18.8)	11 (13.7)	0.42
CCI score
Low, CCI = 0	13 (9.8)	2 (3.7)	11 (13)	0.23
Moderate, CCI = 1–2	50 (37.6)	18 (34)	32 (40)	0.71
High, CCI > 2	70 (52.6)	33 (62)	37 (47)	0.09
Indications for endoscopic retrograde cholangiopancreatography
Choledocholithiasis	41 (30.8)	18 (34)	23 (28.7)
Mass	16 (12)	6 (11.3)	10 (12.5)
Cholestatic liver injury	47 (35.3)	17 (32)	30 (37.5)
Stent exchange/removal	16 (12)	8 (15)	8 (10)
Others	13 (9.8)	4 (7.5)	9 (11.2)
American Society for Gastrointestinal Endoscopy grade				0.37
Grade 1, 2	106 (79.7)	44 (83.7)	62 (77.3)
Grade 3, 4	27 (20.3)	9 (16.3)	18 (22.7)
Mean total procedure time (minutes)	47.1	48.8	45.9	0.6

CCI: Charlson Comorbidity Index.